| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/16/2004 | CN1505618A Dimeric isoflavones |
| 06/16/2004 | CN1505513A Aqueous cilostazol preparation for injection |
| 06/16/2004 | CN1505512A A stable pharmaceutical formulation comprising torsemide modification II |
| 06/16/2004 | CN1504752A Vaughan Tristan J. |
| 06/16/2004 | CN1504569A Chromatography purification process of viper venom blood clotting enzyme |
| 06/16/2004 | CN1504478A Burnet general saponin extract , its preparation method and use |
| 06/16/2004 | CN1504186A Large volume injection liquid of ethylenediamine diaceturate and its preparation method |
| 06/16/2004 | CN1153780C Protein with thrombopoiesis substance activity |
| 06/16/2004 | CN1153770C Substitued nitrogen heterocyclic ring as inhibitors of P38 protein kinase |
| 06/16/2004 | CN1153590C Blood substitute of hemoglobin microcapsule and preparing method thereof |
| 06/15/2004 | US6750353 Preparation of pharmaceutically acceptable atorvastatin salts in non-crystalline form |
| 06/15/2004 | US6750323 Platelet activation protein |
| 06/15/2004 | US6750253 Aminobenzophenones as inhibitors of il-1β and tnf-α |
| 06/15/2004 | US6750243 COMPETITIVE INHIBITORS OF TRYPSIN-LIKE SERINE PROTEASES, ESPECIALLY THROMBIN; chemical synthesis; anticoagulants; treatment of thrombosis |
| 06/15/2004 | US6750239 Useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 06/15/2004 | US6750232 2-aminopyridine compounds and use thereof as drugs |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750225 Anticoagulants |
| 06/15/2004 | US6750219 Having integrin alpha v beta 3 antagonistic activity, gp iib/iiia antagonistic activity, and/or human platelet aggregation inhibitory activity and also having excellent water solubility |
| 06/15/2004 | US6750214 Quinoline and quinazoline compounds useful in therapy |
| 06/15/2004 | US6750212 Photochemotherapeutic compositions |
| 06/15/2004 | US6750034 Useful as therapeutic agents for cancer, skin disorders, neuropathic pain, inflammatory, or coagulation diathesis/thrombosis; may also be useful for laundry detergents and skin care products; derived from humans |
| 06/15/2004 | US6750026 To diagnose diseases relating to under- or over-expression of hfgan72 receptor ligands; for treatment of obesity, diabetes, anorexia nervosa, bulimia, cachexia, chronic renal failure, congestive heart failure |
| 06/15/2004 | US6749851 Applying radiation |
| 06/15/2004 | CA2159330C Inhibition of leukocyte adhesion |
| 06/10/2004 | WO2004049095A2 Betaine and salicylic acid compositions |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048565A1 Apoptosis-associated protein and use thereof |
| 06/10/2004 | WO2004048401A1 Peptides and medicinal compositions containing the same |
| 06/10/2004 | WO2004048363A1 Imidazole derivative, process for producing the same, and use |
| 06/10/2004 | WO2004047858A1 Novel use of erythropoietin in heart diseases |
| 06/10/2004 | WO2004047760A2 Novel chemical compounds |
| 06/10/2004 | WO2004004698A3 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/10/2004 | WO2004002405A3 Amino-bicyclic pyrazinones and pyridinones |
| 06/10/2004 | WO2004000225A3 Use of thio-oxindole derivatives in treatment of hormone-related conditions |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003072027A3 Compositions and formulations of 9- nitrocamptothecin polymorphs and methods of use thereof |
| 06/10/2004 | WO2003066842A3 Method for producing recombinant proteins in micro-organisms |
| 06/10/2004 | US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide |
| 06/10/2004 | US20040110946 such as ethyl-2-[6-amino-4-(1,3-benzodioxol-5-yl)-3,5-dicyano-2-pyridinyl]propionate; drug screening; for treatment of cardiovascular disorders/diabetes |
| 06/10/2004 | US20040110919 Comprises toxic jellyfish protein for use as pesticide |
| 06/10/2004 | US20040110840 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 06/10/2004 | US20040110833 administering a patient an ester of an alpha-ketoalkanoic acid selected from alpha-ketopropionic acid (pyruvate), alpha-keto-butyrate, alpha-ketopentanoate, alpha-keto-3-methyl-pentanoate etc. to treat cytokine mediated inflammatory conditions |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110810 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 06/10/2004 | US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione |
| 06/10/2004 | US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair |
| 06/10/2004 | US20040110803 especially salts, prodrugs or active derivatives thereof; optionally coadministering a compound that interferes with fatty acid synthesis. |
| 06/10/2004 | US20040110769 Antitumor agents for cancer treatment; 5-(3-chlorophenyl)-alpha-(4-chlorophenyl)-alpha-(1-methyl-1H-imidazol-5-yl)tetrazolo[1,5-a]quinazoline-7-methanamine with tamoxifen for example |
| 06/10/2004 | US20040110768 (S)-3-(1H-indol-3-yl)-N-(1-methoxymethyl-cyclohexylmethyl)-2-methyl-2-[4-(4-nitro-phenyl)-oxazol-2-ylamino]-propionamide for example; cancer, psychological disorders, sexual disorders, eating disorders, inflammatory bowel disease, sleep disorders |
| 06/10/2004 | US20040110763 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/10/2004 | US20040110744 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110709 Genetic modification of the lung as a portal for gene delivery |
| 06/10/2004 | US20040110679 Administering erythropoietin or derivative to human suffering from diabetes |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040109907 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 06/10/2004 | US20040109858 Conformation-specific anti-von Willebrand factor antibodies |
| 06/10/2004 | US20040109847 Treatment and prophylaxis with 4-1BB-binding agents |
| 06/10/2004 | CA2507616A1 Highly stable pacap/vip-derived peptides |
| 06/10/2004 | CA2507256A1 Thiazolidine compounds in the treatment of anemic conditions |
| 06/10/2004 | CA2507026A1 Imidazole derivatives, their production and use |
| 06/10/2004 | CA2505524A1 Novel use of erythropoietin in heart diseases |
| 06/09/2004 | EP1426364A1 Imidazole-derivatives as factor Xa inhibitors |
| 06/09/2004 | EP1426050A1 Jnk inhibitors |
| 06/09/2004 | EP1425304A2 G-csf conjugates |
| 06/09/2004 | EP1425284A2 Furo- and thienopyrimidine derivatives as angiogenesis inhibitors |
| 06/09/2004 | EP1425258A2 Hydroxyeicosenoic acid analogs |
| 06/09/2004 | EP1425047A1 Method for improving oxygen transport by stored red blood cells |
| 06/09/2004 | EP1425034A1 Method for treating coumarin-induced hemorrhage |
| 06/09/2004 | EP1425028A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 06/09/2004 | EP1425020A1 Methods and compositions for treating apoptosis associated disorders |
| 06/09/2004 | EP1425015A2 Tetrahydroquinoline derivatives as antithrombotic agents |
| 06/09/2004 | EP1425010A1 Substituted indoles and their use as integrin antagonists |
| 06/09/2004 | EP1425009A2 Peptide arginals and methods for treating disseminated intravascular coagulation |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424994A1 Preparation of sustained release pharmaceutical composition |
| 06/09/2004 | EP1424971A1 Eustachian tube stent |
| 06/09/2004 | EP1212323B1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/09/2004 | EP1196412B1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 06/09/2004 | EP1148875B1 Methods and compositions to enhance white blood cell count |
| 06/09/2004 | EP1100795B1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 06/09/2004 | EP1054687A4 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 06/09/2004 | EP1043310B1 Biphenylamidine derivatives |
| 06/09/2004 | EP1021134A4 Use of hemoglobin to prevent sepsis or treat systemic inflammatory response syndrome |
| 06/09/2004 | EP0980366B1 Antithrombotic agents |
| 06/09/2004 | EP0956294B1 Thrombin inhibitors |
| 06/09/2004 | EP0892786B1 New carboxylic acid derivatives, their production and use |
| 06/09/2004 | CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors |
| 06/09/2004 | CN1503784A 2-lminopyrrolidine derivatives |
| 06/09/2004 | CN1503677A Use of LP 82 to treat hematopoietic disorders |
| 06/09/2004 | CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/09/2004 | CN1502352A Medicine for treatnig endometrorrhagia |
| 06/09/2004 | CN1502331A Anti-angiogenic compositions and methods of use |
| 06/09/2004 | CN1502328A Lamiophlomis rotate dispersion table preparation process |
| 06/09/2004 | CN1152867C Quinazoline derivatives as medicaments |
| 06/09/2004 | CN1152866C Benzimidazoles, production thereof and use thereof medicaments |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152713C Dried blood factor composition comprising trehalose |
| 06/09/2004 | CN1152675C IL-8 receptor antagonists |